Bioelectronics Corp (BIEL)

[Jimzin]

currently "the share structure" is 25 billion authorized shares.
the current outstanding shares is somewhere +/- 23B.
So you can probably take it to the bank that we will reach the 25B Authorized shares = 25B Outstanding shares limit in 2020.

The promissory notes, convertible to BIEL shares are first and foremost cash loans. So there is a presumption they could become shares, but also it is presumable they could be paid in cash with interest due. I am a holder of one of these promissory notes and I presume my loan will be paid in full in cash when BIEL is profitable or bought out. Either way is ok with me.

The IBEX loan program is not the problem...it's our friend actually.

our problem is much much worse than needing money...

BIEL #1 issue is the market perception and global partner perception. BIEL is toxic, just ask CVS and B Braun and Boots and Protex and SEC and 99% of shareholders. LOL!